Metabolomics Market by Technique and Application - Global Industry Analysis and Forecast to 2027

Published On : May 2022 Pages : 97 Category: Medical Devices Report Code : HC0635

Industry Trend Analysis

The global metabolomics market is expected to be around $2.5 billion by 2027. Increase in demand for personalized medicines, rapid development in pharmaceutical and biotech sectors, increase in prevalence of target diseases, and rising demand for toxicology technologies are major factors contributing to the market growth. However, high cost of associated instruments and tools, unwillingness to adopt advanced technology for data processing by traditional professionals and dearth of skilled workforce can impact the growth of the market.

Technique Outlook and Trend Analysis

High performance liquid chromatography (HPLC) segment accounted for the major share of the global metabolomics market in 2017. This large share can be attributed to factors such as high speed, accuracy, and efficiency of the procedure. HPLC market is expected to maintain its dominance during the forecast period owing to its large number of applications in clinical diagnosis of diseases, high adoption in pharmaceutical labs for analysis and for separation of similar molecules in clinical research.

Application Outlook and Trend Analysis

Biomarker discovery segment accounted for the major share of the overall market in 2017. This major share is primarily attributed to factors such as reliability and effectiveness of metabolic profiling of the biomarkers and efficiency in managing diseases at metabolic level through metabolic biomarkers.

Regional Outlook and Trend Analysis

North America accounted for the major share of the overall metabolomics market in 2017. This market dominance can be attributed to various factors such as easy availability of technologically advanced products, increase adoption rate of personalized medicines, and highly developed research infrastructure. Asia-Pacific region is anticipated to witness highest growth during the forecast period owing to factors such as the advancements related to biopharmaceutical research infrastructure, presence of unmet healthcare needs, and rise in prevalence of age-related chronic diseases.

Competitive Analysis

Some of the major players in this market are LECO Corporation, Bio-Rad Laboratories, Inc., Human Metabolome Technologies, Inc., Thermo Fisher Scientific, Inc., Biocrates Life Sciences AG, Shimadzu Corporation, Agilent Technologies, Inc., Waters Corporation, Metabolon, Inc. and Bruker Corporation. Major players in this market are focusing on product innovations to acquire larger share of the global market. For instance, in June 2017, Thermo Fisher launched the Hybrid Quadropole-Orbitrap mass spectrometer to derive exceptional performance and versatility.

Market Opportunities

Metabolomics is gaining high importance in life sciences research owing to its systematic and precise technique to gain vital insights about biological systems. The future opportunities for metabolomics market lie in development of advanced products with enhanced statistical and analytical capabilities.

Metabolomics Market Segmentation

By Technique:

  • Separation Techniques
  • Capillary Electrophoresis
  • High Performance Liquid Chromatography
  • Gas Chromatography
  • Ultra Performance Liquid Chromatography
  • Detection Techniques
  • Nuclear Magnetic Resonance Spectroscopy
  • Mass Spectrometry

By Application:

  • Drug Assessment
  • Nutrigenomics
  • Clinical toxicology
  • Biomarker Discovery
  • Others

By Region:

  • North America
  • U.S
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia-Pacific
  • Rest of the World
  • Brazil
  • South Africa
  • Saudi Arabia
  • Turkey
  • United Arab Emirates
  • Others

Some of the key questions answered by the report are:

  • What was the market size in 2017 and forecast from 2022 to 2027?
  • What will be the industry market growth from 2022 to 2027?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

  • Metabolomics Market, By Technique, Estimates and Forecast, 2017-2027 ($Million)
    • Separation Techniques
  • High Performance Liquid Chromatography
  • Ultra Performance Liquid Chromatography
  • Gas Chromatography
  • Capillary Electrophoresis
  • Detection Techniques
  • Mass Spectrometry
  • Nuclear Magnetic Resonance Spectroscopy
  • Metabolomics Market, By Application, Estimates and Forecast, 2017-2027 ($Million)
    • Nutrigenomics
    • Biomarker Discovery
    • Clinical toxicology
    • Drug Assessment
    • Others
  • Metabolomics Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
    • North America
  • North America Metabolomics Market, By Country
  • North America Metabolomics Market, By Technique
  • North America Metabolomics Market, By Application
    • U.S. Metabolomics Market, By Technique
    • U.S. Metabolomics Market, By Application
    • Canada Metabolomics Market, By Technique
    • Canada Metabolomics Market, By Application
    • Mexico Metabolomics Market, By Technique
    • Mexico Metabolomics Market, By Application
    • Europe
  • Europe Metabolomics Market, By Country
  • Europe Metabolomics Market, By Technique
  • Europe Metabolomics Market, By Application
    • Germany Metabolomics Market, By Product
    • Germany Metabolomics Market, By Application
    • France Metabolomics Market, By Technique
    • France Metabolomics Market, By Application
    • UK Metabolomics Market, By Technique
    • UK Metabolomics Market, By Application
    • Italy Metabolomics Market, By Technique
    • Italy Metabolomics Market, By Application
    • Spain Metabolomics Market, By Technique
    • Spain Metabolomics Market, By Application
    • Rest of Europe Metabolomics Market, By Technique
    • Rest of Europe Metabolomics Market, By Application
    • Asia-Pacific
      • Asia-Pacific Metabolomics Market, By Country
      • Asia-Pacific Metabolomics Market, By Technique
      • Asia-Pacific Metabolomics Market, By Application
        • Japan Metabolomics Market, By Technique
        • Japan Metabolomics Market, By Application
        • China Metabolomics Market, By Technique
        • China Metabolomics Market, By Application
        • Australia Metabolomics Market, By Technique
        • Australia Metabolomics Market, By Application
        • India Metabolomics Market, By Technique
        • India Metabolomics Market, By Application
        • South Korea Metabolomics Market, By Technique
        • South Korea Metabolomics Market, By Application
        • Rest of Asia-Pacific Metabolomics Market, By Technique
        • Rest of Asia-Pacific Metabolomics Market, By Application
    • Rest of the World
      • Rest of the World Metabolomics Market, By Country
      • Rest of the World Metabolomics Market, By Technique
      • Rest of the World Metabolomics Market, By Application
        • Brazil Metabolomics Market, By Technique
        • Brazil Metabolomics Market, By Application
        • South Africa Metabolomics Market, By Technique
        • South Africa Metabolomics Market, By Application
        • Saudi Arabia Metabolomics Market, By Technique
        • Saudi Arabia Metabolomics Market, By Application
        • Turkey Metabolomics Market, By Technique
        • Turkey Metabolomics Market, By Application
        • United Arab Emirates Metabolomics Market, By Technique
        • United Arab Emirates Metabolomics Market, By Application
        • Other Metabolomics Market, By Technique
        • Other Metabolomics Market, By Application

Table of Contents

1.       Introduction

1.1.       Report Description

1.2.       Research Methodology

1.2.1.  Secondary Research

1.2.2.  Primary Research

2.       Executive Summary

2.1.       Key Highlights

3.       Market Overview

3.1.       Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.       Market Share Analysis

3.3.       Market Dynamics

3.3.1.  Drivers

3.3.1.1.    Rising Demand for Personalized Medicines

3.3.1.2.    Increase in Prevalence of Target Diseases

3.3.1.3.    Rapid Development in Pharmaceutical and Biotech Sectors

3.3.2.  Restraints

3.3.2.1.    High Cost of Instruments

3.3.2.2.    Dearth of Skilled Professionals

3.3.3.  Opportunities

3.3.3.1.    Emerging Market to Offer Lucrative Growth Opportunities

3.4.       Industry Trends

3.5.       Reimbursement Scenario

4.       Metabolomics Market, By Technique

4.1.       Introduction

4.2.       Metabolomics Market Assessment and Forecast, By Technique, 2017-2027

4.3.       Separation Techniques

4.3.1.  Market Assessment and Forecast, By Type, 2017-2027 ($Million)

4.3.2.  Market Assessment and Forecast, By Region, 2017-2027 ($Million)

4.3.3.   High Performance Liquid Chromatography

4.3.3.1.    Market Assessment and Forecast, By Region, 2017-2027 ($Million).

4.3.4.  Ultra Performance Liquid Chromatography

4.3.4.1.    Market Assessment and Forecast, By Region, 2017-2027 ($Million).

4.3.5.  Gas Chromatography

4.3.5.1.    Market Assessment and Forecast, By Region, 2017-2027 ($Million).

4.3.6.  Capillary Electrophoresis

4.3.6.1.    Market Assessment and Forecast, By Region, 2017-2027 ($Million).

4.4.       Detection Techniques

4.4.1.  Market Assessment and Forecast, By Type, 2017-2027 ($Million)

4.4.2.  Market Assessment and Forecast, By Region, 2017-2027 ($Million)

4.4.3.  Mass Spectrometry

4.4.3.1.    Market Assessment and Forecast, By Region, 2017-2027 ($Million).

4.4.4.  Nuclear Magnetic Resonance Spectroscopy

4.4.4.1.    Market Assessment and Forecast, By Region, 2017-2027 ($Million).

5.       Metabolomics Market, By Application

5.1.       Introduction

5.2.       Metabolomics Market Assessment and Forecast, By Application, 2017-2027

5.3.       Nutrigenomics

5.3.1.  Market Assessment and Forecast, By Region, 2017-2027 ($Million)

5.4.       Biomarker Discovery

5.4.1.  Market Assessment and Forecast, By Region, 2017-2027 ($Million)

5.5.       Clinical Toxicology

5.5.1.  Market Assessment and Forecast, By Region, 2017-2027 ($Million)

5.6.       Drug Assessment

5.6.1.  Market Assessment and Forecast, By Region, 2017-2027 ($Million)

5.7.       Others

5.7.1.  Market Assessment and Forecast, By Region, 2017-2027 ($Million)

6.       Metabolomics Market, By Region

6.1.       Introduction

6.2.       3D Printing Medical Device Assessment and Forecast, By Region, 2017-2027 ($Million)

6.3.       North America

6.3.1.  Market Assessment and Forecast, By Country, 2017-2027 ($Million)

6.3.2.  Market Assessment and Forecast, By Technique, 2017-2027 ($Million)

6.3.3.  Market Assessment and Forecast, By Application, 2017-2027 ($Million)

6.3.3.1.    U.S.

6.3.3.1.1.    Market Assessment and Forecast, By Technique, 2017-2027 ($Million)

6.3.3.1.2.    Market Assessment and Forecast, By Application, 2017-2027 ($Million)

6.3.3.2.    Canada

6.3.3.2.1.    Market Assessment and Forecast, By Technique, 2017-2027 ($Million)

6.3.3.2.2.    Market Assessment and Forecast, By Application, 2017-2027 ($Million)

6.3.3.3.    Mexico

6.3.3.3.1.    Market Assessment and Forecast, By Technique, 2017-2027 ($Million)

6.3.3.3.2.    Market Assessment and Forecast, By Application, 2017-2027 ($Million)

6.4.       Europe

6.4.1.  Market Assessment and Forecast, By Country, 2017-2027 ($Million)

6.4.2.  Market Assessment and Forecast, By Technique, 2017-2027 ($Million)

6.4.3.  Market Assessment and Forecast, By Application, 2017-2027 ($Million)

6.4.3.1.    Germany

6.4.3.1.1.    Market Assessment and Forecast, By Technique, 2017-2027 ($Million)

6.4.3.1.2.    Market Assessment and Forecast, By Application, 2017-2027 ($Million)

6.4.3.2.    France

6.4.3.2.1.    Market Assessment and Forecast, By Technique, 2017-2027 ($Million)

6.4.3.2.2.    Market Assessment and Forecast, By Application, 2017-2027 ($Million)

6.4.3.3.    UK

6.4.3.3.1.    Market Assessment and Forecast, By Technique, 2017-2027 ($Million)

6.4.3.3.2.    Market Assessment and Forecast, By Application, 2017-2027 ($Million)

6.4.3.4.    Italy

6.4.3.4.1.    Market Assessment and Forecast, By Technique, 2017-2027 ($Million)

6.4.3.4.2.    Market Assessment and Forecast, By Application, 2017-2027 ($Million)

6.4.3.5.    Spain

6.4.3.5.1.    Market Assessment and Forecast, By Technique, 2017-2027 ($Million)

6.4.3.5.2.    Market Assessment and Forecast, By Application, 2017-2027 ($Million)

6.4.3.6.    Russia

6.4.3.6.1.    Market Assessment and Forecast, By Technique, 2017-2027 ($Million)

6.4.3.6.2.    Market Assessment and Forecast, By Application, 2017-2027 ($Million)

6.4.3.7.    Rest of Europe

6.4.3.7.1.    Market Assessment and Forecast, By Technique, 2017-2027 ($Million)

6.4.3.7.2.    Market Assessment and Forecast, By Application, 2017-2027 ($Million)

6.5.       Asia-Pacific

6.5.1.  Market Assessment and Forecast, By Country, 2017-2027 ($Million)

6.5.2.  Market Assessment and Forecast, By Technique, 2017-2027 ($Million)

6.5.3.  Market Assessment and Forecast, By Application, 2017-2027 ($Million)

6.5.3.1.    Japan

6.5.3.1.1.    Market Assessment and Forecast, By Technique, 2017-2027 ($Million)

6.5.3.1.2.    Market Assessment and Forecast, By Application, 2017-2027 ($Million)

6.5.3.2.    China

6.5.3.2.1.    Market Assessment and Forecast, By Technique, 2017-2027 ($Million)

6.5.3.2.2.    Market Assessment and Forecast, By Application, 2017-2027 ($Million)

6.5.3.3.    Australia

6.5.3.3.1.    Market Assessment and Forecast, By Technique, 2017-2027 ($Million)

6.5.3.3.2.    Market Assessment and Forecast, By Application, 2017-2027 ($Million)

6.5.3.4.    India

6.5.3.4.1.    Market Assessment and Forecast, By Product, 2017-2027 ($Million)

6.5.3.4.2.    Market Assessment and Forecast By Application, 2017-2027 ($Million)

6.5.3.5.    South Korea

6.5.3.5.1.    Market Assessment and Forecast, By Technique, 2017-2027 ($Million)

6.5.3.5.2.    Market Assessment and Forecast, By Application, 2017-2027 ($Million)

6.5.3.6.    Taiwan

6.5.3.6.1.    Market Assessment and Forecast, By Technique, 2017-2027 ($Million)

6.5.3.6.2.    Market Assessment and Forecast, By Application, 2017-2027 ($Million)

6.5.3.7.    Rest of Asia-Pacific

6.5.3.7.1.    Market Assessment and Forecast, By Technique, 2017-2027 ($Million)

6.5.3.7.2.    Market Assessment and Forecast, By Application, 2017-2027 ($Million)

6.6.       Rest of the World

6.6.1.  Market Assessment and Forecast, By Country, 2017-2027 ($Million)

6.6.2.  Market Assessment and Forecast, By Technique, 2017-2027 ($Million)

6.6.3.  Market Assessment and Forecast, By Application, 2017-2027 ($Million)

6.6.3.1.    Brazil

6.6.3.1.1.    Market Assessment and Forecast, By Technique, 2017-2027 ($Million)

6.6.3.1.2.    Market Assessment and Forecast, By Application, 2017-2027 ($Million)

6.6.3.2.    Saudi Arabia

6.6.3.2.1.    Market Assessment and Forecast, By Technique, 2017-2027 ($Million)

6.6.3.2.2.    Market Assessment and Forecast, By Application, 2017-2027 ($Million)

6.6.3.3.    South Africa

6.6.3.3.1.    Market Assessment and Forecast, By Technique, 2017-2027 ($Million)

6.6.3.3.2.    Market Assessment and Forecast, By Application, 2017-2027 ($Million)

6.6.3.4.    United Arab Emirates

6.6.3.4.1.    Market Assessment and Forecast, By Technique, 2017-2027 ($Million)

6.6.3.4.2.    Market Assessment and Forecast, By Application, 2017-2027 ($Million)

6.6.3.5.    Others

6.6.3.5.1.    Market Assessment and Forecast, By Technique, 2017-2027 ($Million)

6.6.3.5.2.    Market Assessment and Forecast, By Application, 2017-2027 ($Million)

7.       Company Profiles

7.1.       LECO Corporation

7.1.1.  Business Overview

7.1.2.  Product Portfolio

7.1.3.  Key Financials

7.1.4.  Strategic Developments

7.2.       Bio-Rad Laboratories, Inc.

7.2.1.  Business Overview

7.2.2.  Product Portfolio

7.2.3.  Key Financials

7.2.4.  Strategic Developments

7.3.       Human Metabolome Technologies, Inc.,

7.3.1.  Business Overview

7.3.2.  Product Portfolio

7.3.3.  Key Financials

7.3.4.  Strategic Developments

7.4.       Thermo Fisher Scientific, Inc.

7.4.1.  Business Overview

7.4.2.  Product Portfolio

7.4.3.  Key Financials

7.4.4.  Strategic Developments

7.5.       Biocrates Life Sciences AG

7.5.1.  Business Overview

7.5.2.  Product Portfolio

7.5.3.  Key Financials

7.5.4.  Strategic Developments

7.6.       Shimadzu Corporation

7.6.1.  Business Overview

7.6.2.  Product Portfolio

7.6.3.  Key Financials

7.6.4.  Strategic Developments

7.7.       Agilent Technologies, Inc.

7.7.1.  Business Overview

7.7.2.  Product Portfolio

7.7.3.  Key Financials

7.7.4.  Strategic Developments

7.8.       Waters Corporation

7.8.1.  Business Overview

7.8.2.  Product Portfolio

7.8.3.  Key Financials

7.8.4.  Strategic Developments

7.9.       Metabolon, Inc.

7.9.1.  Business Overview

7.9.2.  Product Portfolio

7.9.3.  Key Financials

7.9.4.  Strategic Developments

7.10.    Bruker Corporation

7.10.1.      Business Overview

7.10.2.      Product Portfolio

7.10.3.      Key Financials

7.10.4.      Strategic Developments


List of Tables

Table 1.Global Metabolomics Market, By Technology, 2017-2025 ($Million)
Table 2.Separation Techniques Market, By Type, 2017-2025 ($Million)
Table 3.Separation Techniques Market, By Region, 2017-2025 ($Million)
Table 4.Gas Chromatography Market, By Region, 2017-2025 ($Million)
Table 5.Capillary Electrophoresis Market, By Region, 2017-2025 ($Million)
Table 6.High Performance Liquid Chromatography Market, By Region, 2017-2025 ($Million)
Table 7.Ultra Performance Liquid Chromatography Market, By Region, 2017-2025 ($Million)
Table 8.Detection Techniques Market, By Type, 2017-2025 ($Million)
Table 9.Detection Techniques Market, By Region, 2017-2025 ($Million)
Table 10Nuclear Magnetic Resonance Spectroscopy Market, By Region, 2017-2025 ($Million)
Table 11.Mass Spectrometry Market, By Region, 2017-2025 ($Million)
Table 12.GlobalMetabolomics Market, By Application, 2017-2025 ($Million)
Table 13.Drug Assessment Market, By Region, 2017-2025 ($Million)
Table 14.Biomarker Discovery Market, By Region, 2017-2025 ($Million)
Table 15.Nutrigenomics Market, By Region, 2017-2025 ($Million)
Table 16.Clinical toxicology Market, By Region, 2017-2025 ($Million)
Table 17.Other Market, By Region, 2017-2025 ($Million)
Table 18.Metabolomics Market, By Region, 2017-2025 ($Million)
Table 19.North America Metabolomics Market, By Country, 2017-2025 ($Million)
Table 20.North America Metabolomics Market, By Technique, 2017-2025 ($Million)
Table 21.North America Metabolomics Market, By Application, 2017-2025 ($Million)
Table 22.U.S. Metabolomics Market, By Technique, 2017-2025 ($Million)
Table 23.U.S. Metabolomics Market, By Application, 2017-2025 ($Million)
Table 24.Canada Metabolomics Market, By Technique, 2017-2025 ($Million)
Table 25.Canada Metabolomics Market, By Application, 2017-2025 ($Million)
Table 26.Mexico Metabolomics Market, By Technique, 2017-2025 ($Million)
Table 27.Mexico Metabolomics Market, By Application, 2017-2025 ($Million)
Table 28.Europe Metabolomics Market, By Country, 2017-2025 ($Million)
Table 29.Europe Metabolomics Market, By Technique, 2017-2025 ($Million)
Table 30.Europe Metabolomics Market, By Application, 2017-2025 ($Million)
Table 31.Germany Metabolomics Market, By Technique, 2017-2025 ($Million)
Table 32.Germany Metabolomics Market, By Application, 2017-2025 ($Million)
Table 33.France Metabolomics Market, By Technique, 2017-2025 ($Million)
Table 34.France Metabolomics Market, By Application, 2017-2025 ($Million)
Table 35.UK Metabolomics Market, By Technique, 2017-2025 ($Million)
Table 36.UK Metabolomics Market, By Application, 2017-2025 ($Million)
Table 37.Italy Metabolomics Market, By Technique, 2017-2025 ($Million)
Table 38.Italy Metabolomics Market, By Application, 2017-2025 ($Million)
Table 39.Spain Metabolomics Market, By Technique, 2017-2025 ($Million)
Table 40.Spain Metabolomics Market, By Application, 2017-2025 ($Million)
Table 41.Rest of Europe Metabolomics Market, By Technique, 2017-2025 ($Million)
Table 42.Rest of Europe Metabolomics Market, By Application, 2017-2025 ($Million)
Table 43.Asia-Pacific Metabolomics Market, By Country, 2017-2025 ($Million)
Table 44.Asia-Pacific Metabolomics Market, By Technique, 2017-2025 ($Million)
Table 45.Asia-Pacific Metabolomics Market, By Application, 2017-2025 ($Million)
Table 46.Japan Metabolomics Market, By Technique, 2017-2025 ($Million)
Table 47.Japan Metabolomics Market, By Application, 2017-2025 ($Million)
Table 48.China Metabolomics Market, By Technique, 2017-2025 ($Million)
Table 49.China Metabolomics Market, By Application, 2017-2025 ($Million)
Table 50.Australia Metabolomics Market, By Technique, 2017-2025 ($Million)
Table 51.Australia Metabolomics Market, By Application, 2017-2025 ($Million)
Table 52.India Metabolomics Market, By Technique, 2017-2025 ($Million)
Table 53.India Metabolomics Market, By Application, 2017-2025 ($Million)
Table 54.South Korea Metabolomics Market, By Technique, 2017-2025 ($Million)
Table 55.South Korea Metabolomics Market, By Application, 2017-2025 ($Million)
Table 56.Taiwan Metabolomics Market, By Technique, 2017-2025 ($Million)
Table 57.Taiwan Metabolomics Market, By Application, 2017-2025 ($Million)
Table 58.Rest of Asia-Pacific Metabolomics Market, By Technique, 2017-2025 ($Million)
Table 59.Rest of Asia-Pacific Metabolomics Market,By Application, 2017-2025 ($Million)
Table 60.Rest of the World Metabolomics Market, By Country, 2017-2025 ($Million)
Table 61.Rest of the World Metabolomics Market, By Technique, 2017-2025 ($Million)
Table 62.Rest of the World Metabolomics Market, By Application, 2017-2025 ($Million)
Table 63.Brazil Metabolomics Market, By Technique, 2017-2025 ($Million)
Table 64.Brazil Metabolomics Market, By Application, 2017-2025 ($Million)
Table 65.Turkey Metabolomics Market, By Technique, 2017-2025 ($Million)
Table 66.Turkey Metabolomics Market, By Application, 2017-2025 ($Million)
Table 67.Saudi Arabia Metabolomics Market, By Technique, 2017-2025 ($Million)
Table 68.Saudi Arabia Metabolomics Market, By Application, 2017-2025 ($Million)
Table 69.South Africa Metabolomics Market, By Technique, 2017-2025 ($Million)
Table 70.South Africa Metabolomics Market, By Application, 2017-2025 ($Million)
Table 71.United Arab Emirates Metabolomics Market, By Technique, 2017-2025 ($Million)
Table 72.United Arab Emirates Metabolomics Market, By Application, 2017-2025 ($Million)
Table 73.Other Metabolomics Market, By Technique, 2017-2025 ($Million)
Table 74.Other Metabolomics Market, By Application, 2017-2025 ($Million)
Table 75.LECO Corporation: Key Strategic Developments, 2017-2017
Table 76.Bio-Rad Laboratories, Inc.: Key Strategic Developments, 2017-2017
Table 77.Human Metabolome Technologies, Inc., Key Strategic Developments, 2017-2017
Table 78.Thermo Fisher Scientific, Inc.: Key Strategic Developments, 2017-2017
Table 79.Biocrates Life Sciences AG: Key Strategic Developments, 2017-2017
Table 80.Shimadzu Corporation: Key Strategic Developments, 2017-2017
Table 81.Agilent Technologies, Inc.: Key Strategic Developments, 2017-2017
Table 82.Waters Corporation: Key Strategic Developments, 2017-2017
Table 83.Metabolon, Inc.: Key Strategic Developments, 2017-2017
Table 84.Bruker Corporation: Key Strategic Developments, 2017-2017


List of Figures

Figure 1.Global Metabolomics Market Share, By Technique, 2017 & 2025
Figure 2.Global Metabolomics Market, By Application, 2017, ($Million)
Figure 3.Metabolomics Market, By Region, 2017, ($Million)
Figure 4.LECO Corporation: Net Revenues, 2017-2017 ($Million)
Figure 5.LECO Corporation: Net Revenue Share, By Segment, 2017
Figure 6.LECO Corporation: Net Revenue Share, By Geography, 2017
Figure 7.Bio-Rad Laboratories, Inc.: Net Revenues, 2017-2017 ($Million)
Figure 8.Bio-Rad Laboratories: Net Revenue Share, By Segment, 2017
Figure 9.Bio-Rad Laboratories: Net Revenue Share, By Geography, 2017
Figure 10.Human Metabolome Technologies, Inc.: Net Revenues, 2017-2017 ($Million)
Figure 11.Human Metabolome Technologies, Inc.: Net Revenue Share, By Segment, 2017
Figure 12.Human Metabolome Technologies, Inc.: Net Revenue Share, By Geography, 2017
Figure 13.Thermo Fisher Scientific, Inc.: Net Revenues, 2017-2017 ($Million)
Figure 14.Thermo Fisher Scientific, Inc.: Net Revenue Share, By Segment, 2017
Figure 15.Thermo Fisher Scientific, Inc.: Net Revenue Share, By Geography, 20s16
Figure 16.Biocrates Life Sciences AG: Net Revenues, 2017-2017 ($Million)
Figure 17.Biocrates Life Sciences AG: Net Revenue Share, By Segment, 2017
Figure 18.Biocrates Life Sciences AG: Net Revenue Share, By Geography, 2017
Figure 19.Shimadzu Corporation: Net Revenues, 2017-2017 ($Million)
Figure 20.Shimadzu Corporation Net Revenue Share, By Segment, 2017
Figure 21.Shimadzu Corporation: Net Revenue Share, By End User, 2017
Figure 22.Agilent Technologies, Inc.: Net Revenues, 2017-2017 ($Million)
Figure 23.Agilent Technologies, Inc.: Net Revenue Share, By Segment, 2017
Figure 24.Agilent Technologies, Inc.: Net Revenue Share, By Geography, 2017
Figure 25.Waters Corporation: Net Revenues, 2017-2017 ($Million)
Figure 26.Waters Corporation: Net Revenue Share, By Segment, 2017
Figure 27.Waters Corporation: Net Revenue Share, By Geography, 2017
Figure 28.Metabolon Inc.: Net Revenues, 2017-2017 ($Million)
Figure 29.Metabolon Inc.: Net Revenue Share, By Segment, 2017
Figure 30.Metabolon Inc.: Net Revenue Share, By Geography, 2017
Figure 31.Bruker Corporation: Net Revenues, 2017-2017 ($Million)
Figure 32.Bruker Corporation: Net Revenue Share, By Segment, 2017
Figure 33.Bruker Corporation: Net Revenue Share, By Geography, 2017

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*